Roche/Genetech

The Next Wave of Radioligand Therapies: 5 Candidates to Watch

SOTYKTU Expands Its Reach as Bristol Myers Squibb Lands Key Approval in Psoriatic Arthritis

Emerging TIL Therapies Poised to Broaden the Landscape Beyond AMTAGVI

BYSANTI Approval Positions Vanda to Compete in the Antipsychotic Market